Yan Xu Selected Research

2,3,7,8-tetrabromodibenzo-4-dioxin

4/2007

Effects of brominated flame retardants and brominated dioxins on steroidogenesis in H295R human adrenocortical carcinoma cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan Xu Research Topics

Disease

427	Neoplasms (Cancer) 05/2024 - 02/2002
101	Infections 04/2024 - 04/2004
86	Inflammation (Inflammations) 09/2024 - 09/2003
65	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2005
64	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 04/2010
55	Breast Neoplasms (Breast Cancer) 04/2024 - 07/2006
42	Multiple Myeloma 04/2024 - 05/2007
42	Carcinogenesis 02/2024 - 02/2002
36	Lung Neoplasms (Lung Cancer) 12/2023 - 08/2007
35	Fibrosis (Cirrhosis) 12/2023 - 01/2008
34	Stomach Neoplasms (Stomach Cancer) 05/2024 - 01/2008
33	Pain (Aches) 04/2024 - 12/2007
33	Hypoxia (Hypoxemia) 01/2024 - 10/2002
33	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 03/2002
32	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 05/2007
32	Wounds and Injuries (Trauma) 04/2024 - 11/2003
31	Parkinson Disease (Parkinson's Disease) 09/2024 - 01/2003
27	COVID-19 12/2024 - 01/2020
25	Stroke (Strokes) 09/2023 - 04/2011
23	Adenocarcinoma of Lung 01/2024 - 04/2010
23	Adenocarcinoma 01/2023 - 02/2002
22	Pneumonia (Pneumonitis) 01/2023 - 02/2003
21	Disease Progression 04/2024 - 02/2013
21	Ischemia 03/2024 - 04/2005
21	Carcinoma (Carcinomatosis) 03/2024 - 02/2002
20	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2023 - 01/2017
19	Hemorrhage 02/2024 - 11/2005
18	Leukemia 10/2023 - 10/2007
17	Dyskinesias (Dyskinesia) 03/2024 - 01/2003
17	Acute Kidney Injury (Acute Renal Failure) 12/2023 - 06/2008
16	Hypertension (High Blood Pressure) 04/2024 - 10/2003
16	Ischemic Stroke 03/2024 - 08/2010
16	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 02/2002
16	Periodontitis 01/2023 - 09/2003
15	Sepsis (Septicemia) 05/2024 - 03/2014
15	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 03/2010
15	Virus Diseases (Viral Diseases) 01/2024 - 08/2002
15	Liver Cirrhosis (Hepatic Cirrhosis) 12/2023 - 02/2009
15	Body Weight (Weight, Body) 11/2023 - 01/2013
14	Colonic Neoplasms (Colon Cancer) 04/2024 - 07/2002
14	Prostatic Neoplasms (Prostate Cancer) 09/2022 - 11/2004
13	Reperfusion Injury 12/2023 - 08/2005
13	Heart Failure 09/2023 - 06/2006
13	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2023 - 06/2002
13	Melanoma (Melanoma, Malignant) 01/2023 - 04/2006
13	Obesity 05/2022 - 08/2011
12	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 02/2009
12	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 03/2009
12	Lung Diseases (Lung Disease) 10/2023 - 10/2004

Drug/Important Bio-Agent (IBA)

153	Proteins (Proteins, Gene)FDA Link 02/2024 - 09/2002
93	Biomarkers (Surrogate Marker)IBA 04/2024 - 02/2002
49	CytokinesIBA 04/2024 - 10/2003
48	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 03/2002
45	MicroRNAs (MicroRNA)IBA 07/2023 - 10/2010
39	Immune Checkpoint InhibitorsIBA 01/2024 - 02/2017
37	RNA (Ribonucleic Acid)IBA 04/2024 - 12/2003
33	Long Noncoding RNAIBA 03/2024 - 09/2014
32	Messenger RNA (mRNA)IBA 03/2024 - 01/2003
29	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 06/2011
29	LipidsIBA 12/2023 - 04/2004
28	ErbB Receptors (EGF Receptor)IBA 03/2024 - 02/2004
25	Therapeutic UsesIBA 03/2024 - 04/2005
25	Transcription Factors (Transcription Factor)IBA 01/2023 - 07/2004
24	Antiviral Agents (Antivirals)IBA 01/2024 - 02/2010
23	AntibodiesIBA 12/2024 - 01/2008
23	Anti-Bacterial Agents (Antibiotics)IBA 09/2024 - 09/2013
23	EnzymesIBA 03/2024 - 03/2003
22	LigandsIBA 08/2023 - 11/2009
21	VaccinesIBA 04/2024 - 08/2002
20	Oxygen (Dioxygen)IBA 01/2024 - 08/2009
19	CateninsIBA 04/2024 - 01/2012
18	Peptides (Polypeptides)IBA 03/2024 - 04/2010
18	AnticoagulantsIBA 02/2024 - 09/2013
18	Tyrosine Kinase InhibitorsIBA 12/2023 - 04/2010
18	lysophosphatidic acidIBA 10/2019 - 09/2002
17	Small Interfering RNA (siRNA)IBA 04/2024 - 09/2006
17	Monoclonal AntibodiesIBA 03/2024 - 03/2005
17	Hemoglobins (Hemoglobin)IBA 11/2022 - 04/2008
16	AntigensIBA 12/2023 - 07/2006
16	Interleukin-6 (Interleukin 6)IBA 01/2023 - 10/2003
15	Levodopa (L Dopa)FDA LinkGeneric 03/2024 - 01/2003
15	Bortezomib (Velcade)FDA Link 01/2024 - 06/2008
15	Caspase 3 (Caspase-3)IBA 12/2023 - 09/2002
15	Phosphotransferases (Kinase)IBA 12/2023 - 09/2002
15	CholesterolIBA 05/2022 - 10/2010
15	Surface-Active Agents (Surfactants)IBA 01/2021 - 09/2003
14	Indicators and Reagents (Reagents)IBA 03/2024 - 04/2006
14	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2023 - 07/2009
14	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2022 - 12/2004
13	CalciumIBA 04/2024 - 09/2006
12	LipopolysaccharidesIBA 05/2024 - 07/2007
12	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 03/2012

Therapy/Procedure

243	Therapeutics 05/2024 - 03/2002
83	Drug Therapy (Chemotherapy) 05/2024 - 11/2005
62	Immunotherapy 04/2024 - 04/2010
18	Radiotherapy 01/2022 - 11/2011
14	Aftercare (After-Treatment) 08/2023 - 03/2002
14	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2022 - 03/2010
13	Transplantation 09/2024 - 03/2008
12	Photothermal Therapy 04/2024 - 01/2017